Targeting fusion proteins in solid tumors: from oncogenic mechanisms to clinical interventions

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• Fusion proteins are key drivers in various solid tumors, including lung, breast, and prostate cancers.
• They play critical roles in tumor initiation and progression via diverse molecular pathways.

Purpose of the Study:

• To review the mechanisms of fusion protein generation and their oncogenic roles in solid tumors.
• To highlight current targeted intervention strategies and research progress.
• To emphasize the need for novel therapeutic approaches.

Main Methods:

• Literature review of fusion protein generation mechanisms and oncogenic functions.
• Classification of fusion proteins based on carcinogenic mechanisms.
• Analysis of current targeted therapies, including small molecule inhibitors, antibody drugs, and gene editing.
• Review of clinical trial case studies.

Main Results:

• Fusion proteins contribute to tumor initiation and progression through multiple molecular mechanisms.
• Targeted therapies, including small molecule inhibitors and gene editing, show promise.
• Clinical case studies demonstrate the effectiveness of targeting fusion proteins.

Conclusions:

• Understanding fusion protein mechanisms is crucial for advancing cancer treatment.
• Development of innovative targeted strategies is urgently needed to improve clinical outcomes.
• Further research into fusion proteins will pave the way for more effective cancer therapies.